A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers

Digital PCR is a new technology that enables detection and quantification of cancer DNA molecules from peripheral blood. Using this technique, we identified mutant PIK3CA DNA in circulating plasma tumor DNA (ptDNA) from a patient with concurrent early stage breast cancer and non-small cell lung canc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jelovac, Danijela, Beaver, Julia A., Balukrishna, Sasidharan, Wong, Hong Yuen, Toro, Patricia Valda, Cimino-Mathews, Ashley, Argani, Pedram, Stearns, Vered, Jacobs, Lisa, VanDenBerg, Dustin, Kessler, Jill, Jeter, Stacie, Park, Ben H., Wolff, Antonio C.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3965626/
https://ncbi.nlm.nih.gov/pubmed/24444464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.humpath.2013.10.016
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares